Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
The Journal of Urology|March 26, 2002
Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progressionRichard Choo, Laurence Klotz, Cyril Danjoux, et al.
The Journal of Urology|July 12, 2005
Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control studyJacek A Kopec, Vivek Goel, Peter S Bunting, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 19, 2013
Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissueAngeline A Giangreco, Avani Vaishnav, Dennis Wagner, et al.
The Journal of Urology|September 18, 2009
A framework for the identification of men at increased risk for prostate cancerMonique J Roobol, Fritz H Schröder, E David Crawford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single PatientsVikas Prasad, Friedemann Zengerling, Jochen P Steinacker, et al.
BMC Medical Informatics and Decision Making|December 16, 2014
Is pathology necessary to predict mortality among men with prostate-cancer?David Margel, David R Urbach, Lorraine L Lipscombe, et al.
Plos One|September 11, 2010
A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistanceSevtap Savas, Laurent Briollais, Irada Ibrahim-zada, et al.
The Canadian Journal of Urology|December 12, 2012
Perineural invasion on prostate biopsy does not predict adverse pathological outcomeMalik Elharram, David Margel, Antonio Finelli, et al.
The Journal of Urology|February 22, 2008
Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detectionAbdullah M Al-Ghamdi, Gina Lockwood, Ants Toi, et al.
Histopathology|August 31, 2018
Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data setMehdi Masoomian, Michelle R Downes, Joan Sweet, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
The Journal of Urology|March 26, 2002
Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progressionRichard Choo, Laurence Klotz, Cyril Danjoux, et al.
The Journal of Urology|July 12, 2005
Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control studyJacek A Kopec, Vivek Goel, Peter S Bunting, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 19, 2013
Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissueAngeline A Giangreco, Avani Vaishnav, Dennis Wagner, et al.
The Journal of Urology|September 18, 2009
A framework for the identification of men at increased risk for prostate cancerMonique J Roobol, Fritz H Schröder, E David Crawford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single PatientsVikas Prasad, Friedemann Zengerling, Jochen P Steinacker, et al.
BMC Medical Informatics and Decision Making|December 16, 2014
Is pathology necessary to predict mortality among men with prostate-cancer?David Margel, David R Urbach, Lorraine L Lipscombe, et al.
Plos One|September 11, 2010
A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistanceSevtap Savas, Laurent Briollais, Irada Ibrahim-zada, et al.
The Canadian Journal of Urology|December 12, 2012
Perineural invasion on prostate biopsy does not predict adverse pathological outcomeMalik Elharram, David Margel, Antonio Finelli, et al.
The Journal of Urology|February 22, 2008
Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detectionAbdullah M Al-Ghamdi, Gina Lockwood, Ants Toi, et al.
Histopathology|August 31, 2018
Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data setMehdi Masoomian, Michelle R Downes, Joan Sweet, et al.
Pageof 27